{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360846640751217536.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.bbmt.2013.12.555"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1083879113011269?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1083879113011269?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"24333750"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Single-Unit Cord Blood Transplantation after Granulocyte Colony-Stimulating Factor–Combined Myeloablative Conditioning for Myeloid Malignancies Not in Remission"}],"description":[{"notation":[{"@value":"High disease burden in myeloablative allogeneic hematopoietic stem cell transplantation is associated with adverse outcomes in patients with acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). Quiescent leukemia stem cells could be induced to enter cell cycle by granulocyte colony-stimulating factor (G-CSF) administration and become more susceptible to chemotherapy. We report on the outcome of unrelated cord blood transplantation (CBT) using a conditioning regimen of 12 Gy total body irradiation, G-CSF-combined high-dose cytarabine, and cyclophosphamide in 61 adult patients with AML or advanced MDS not in remission. With a median follow-up of 97 months, the probability of overall survival and cumulative incidence of relapse at 7 years were 61.4% and 30.5%, respectively. In multivariate analysis, poor-risk cytogenetics and high lactate dehydrogenase values at CBT were independently associated with inferior survival. These data demonstrate that CBT after G-CSF-combined myeloablative conditioning is a promising curative option for patients with myeloid malignancies not in remission."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1420845751146540544","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"00709553"},{"@type":"NRID","@value":"1000000709553"},{"@type":"NRID","@value":"9000001893400"},{"@type":"NRID","@value":"9000414096196"},{"@type":"NRID","@value":"9000021409900"},{"@type":"NRID","@value":"9000410628979"},{"@type":"NRID","@value":"9000409610198"},{"@type":"NRID","@value":"9000410512003"},{"@type":"NRID","@value":"9000021384305"},{"@type":"NRID","@value":"9000018475252"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/konumatakaaki53"}],"foaf:name":[{"@value":"Takaaki Konuma"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003443990522626","@type":"Researcher","foaf:name":[{"@value":"Seiko Kato"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003443990522637","@type":"Researcher","foaf:name":[{"@value":"Jun Ooi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003443990522636","@type":"Researcher","foaf:name":[{"@value":"Maki Oiwa-Monna"}]},{"@id":"https://cir.nii.ac.jp/crid/1420001326226024960","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"90349473"},{"@type":"NRID","@value":"1000090349473"},{"@type":"NRID","@value":"9000364849360"},{"@type":"NRID","@value":"9000256643746"},{"@type":"NRID","@value":"9000397960144"},{"@type":"NRID","@value":"9000364870263"},{"@type":"NRID","@value":"9000345401596"},{"@type":"NRID","@value":"9000258043119"},{"@type":"NRID","@value":"9000368406024"},{"@type":"NRID","@value":"9000256643765"}],"foaf:name":[{"@value":"Shinji Mochizuki"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003443990522638","@type":"Researcher","foaf:name":[{"@value":"Koichiro Yuji"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003443990522625","@type":"Researcher","foaf:name":[{"@value":"Toyotaka Kawamata"}]},{"@id":"https://cir.nii.ac.jp/crid/1420564276173721472","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"40302608"},{"@type":"NRID","@value":"1000040302608"},{"@type":"NRID","@value":"9000000527343"},{"@type":"NRID","@value":"9000258039452"},{"@type":"NRID","@value":"9000016804979"},{"@type":"NRID","@value":"9000256642635"},{"@type":"NRID","@value":"9000256643385"},{"@type":"NRID","@value":"9000256641660"},{"@type":"NRID","@value":"9000256641855"},{"@type":"NRID","@value":"9000256644950"},{"@type":"NRID","@value":"9000256644872"},{"@type":"NRID","@value":"9000256642082"},{"@type":"NRID","@value":"9000256643987"},{"@type":"NRID","@value":"9000256641847"},{"@type":"NRID","@value":"9000368406037"},{"@type":"NRID","@value":"9000412639047"}],"foaf:name":[{"@value":"Yasuhiro Ebihara"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003443990522624","@type":"Researcher","foaf:name":[{"@value":"Kazuaki Yokoyama"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003443990522632","@type":"Researcher","foaf:name":[{"@value":"Kaoru Uchimaru"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003443990522634","@type":"Researcher","foaf:name":[{"@value":"Norihide Jo"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003443990522630","@type":"Researcher","foaf:name":[{"@value":"Arinobu Tojo"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003443990522633","@type":"Researcher","foaf:name":[{"@value":"Satoshi Takahashi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003443990522631","@type":"Researcher","foaf:name":[{"@value":"Nobuhiro Ohno"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003443990522629","@type":"Researcher","foaf:name":[{"@value":"Shigetaka Asano"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"10838791"}],"prism:publicationName":[{"@value":"Biology of Blood and Marrow Transplantation"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2014-03","prism:volume":"20","prism:number":"3","prism:startingPage":"396","prism:endingPage":"401"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license","http://creativecommons.org/licenses/by-nc-nd/4.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1083879113011269?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S1083879113011269?httpAccept=text/plain"}],"createdAt":"2013-12-11","modifiedAt":"2025-10-21","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Adult","dc:title":"Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Transplantation%20Conditioning","dc:title":"Transplantation Conditioning"},{"@id":"https://cir.nii.ac.jp/all?q=Cord%20blood%20transplantation","dc:title":"Cord blood transplantation"},{"@id":"https://cir.nii.ac.jp/all?q=Adolescent","dc:title":"Adolescent"},{"@id":"https://cir.nii.ac.jp/all?q=Acute%20myelogenous%20leukemia","dc:title":"Acute myelogenous leukemia"},{"@id":"https://cir.nii.ac.jp/all?q=Granulocyte%20colony-stimulating%20factor","dc:title":"Granulocyte colony-stimulating factor"},{"@id":"https://cir.nii.ac.jp/all?q=not%20in%20remission","dc:title":"not in remission"},{"@id":"https://cir.nii.ac.jp/all?q=Granulocyte%20Colony-Stimulating%20Factor","dc:title":"Granulocyte Colony-Stimulating Factor"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Transplantation,%20Homologous","dc:title":"Transplantation, Homologous"},{"@id":"https://cir.nii.ac.jp/all?q=Cyclophosphamide","dc:title":"Cyclophosphamide"},{"@id":"https://cir.nii.ac.jp/all?q=Transplantation","dc:title":"Transplantation"},{"@id":"https://cir.nii.ac.jp/all?q=L-Lactate%20Dehydrogenase","dc:title":"L-Lactate Dehydrogenase"},{"@id":"https://cir.nii.ac.jp/all?q=Cytarabine","dc:title":"Cytarabine"},{"@id":"https://cir.nii.ac.jp/all?q=Hematology","dc:title":"Hematology"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Myeloablative%20Agonists","dc:title":"Myeloablative Agonists"},{"@id":"https://cir.nii.ac.jp/all?q=Hematopoietic%20Stem%20Cells","dc:title":"Hematopoietic Stem Cells"},{"@id":"https://cir.nii.ac.jp/all?q=Prognosis","dc:title":"Prognosis"},{"@id":"https://cir.nii.ac.jp/all?q=Survival%20Analysis","dc:title":"Survival Analysis"},{"@id":"https://cir.nii.ac.jp/all?q=Hematopoietic%20Stem%20Cell%20Mobilization","dc:title":"Hematopoietic Stem Cell Mobilization"},{"@id":"https://cir.nii.ac.jp/all?q=Leukemia,%20Myeloid,%20Acute","dc:title":"Leukemia, Myeloid, Acute"},{"@id":"https://cir.nii.ac.jp/all?q=Myelodysplastic%20Syndromes","dc:title":"Myelodysplastic Syndromes"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Cord%20Blood%20Stem%20Cell%20Transplantation","dc:title":"Cord Blood Stem Cell Transplantation"},{"@id":"https://cir.nii.ac.jp/all?q=Myelodysplastic%20syndrome","dc:title":"Myelodysplastic syndrome"},{"@id":"https://cir.nii.ac.jp/all?q=Biomarkers","dc:title":"Biomarkers"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040000782167423360","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23591373"},{"@type":"JGN","@value":"JP23591373"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23591373/"}],"notation":[{"@language":"ja","@value":"患者由来ｉＰＳ細胞を利用した骨髄異形成症候群病態解析モデルの構築"},{"@language":"en","@value":"Establishment of a patient-derived iPS cells for simulating myelodysplastic syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1040000782268272768","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"25670471"},{"@type":"JGN","@value":"JP25670471"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25670471/"}],"notation":[{"@language":"ja","@value":"iPS細胞・ES細胞を用いたダウン症候群における合併症の新規治療法・予防法の開発"},{"@language":"en","@value":"Development and establishment of the treatment of complications in Down syndrome patients using human ES and iPS cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1040000782268304512","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"25670489"},{"@type":"JGN","@value":"JP25670489"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25670489/"}],"notation":[{"@language":"ja","@value":"ヒト胚性幹細胞を用いた胎児造血の分子基盤の解明"},{"@language":"en","@value":"Molecular analysis of fetal hematopoiesis using culture system with ES cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282257177150720","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"24390272"},{"@type":"JGN","@value":"JP24390272"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24390272/"}],"notation":[{"@language":"ja","@value":"ヒトＥＳ細胞を用いた胎児期における自然免疫の発生と発症の解析"},{"@language":"en","@value":"Analysis of human innate immunity and acquired immune mechanism during fetal period using human ES cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282257254074240","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"25893049"},{"@type":"JGN","@value":"JP25893049"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25893049/"}],"notation":[{"@language":"ja","@value":"骨髄異形成症候群幹細胞のクローン進展におけるポリコーム複合体の役割"},{"@language":"en","@value":"The role of polycomb complex on the clonal evolution in myelodysplastic syndrome"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004239210956800","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Early phase mixed chimerism in bone marrow does not affect long-term outcomes of myeloablative single-unit cord blood transplantation for adult patients with hematological malignancies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142743668864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Lower vancomycin trough levels in adults undergoing unrelated cord blood transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142743778816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of a prior history of cancer on prognosis after myeloablative single-unit cord blood transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011143502538752","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prospective Multicenter Study of Single-Unit Cord Blood Transplantation with Myeloablative Conditioning for Adult Patients with High-Risk Hematologic Malignancies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146512630144","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Unrelated Cord Blood Transplantation after Myeloablative Conditioning in Adults with Acute Myelogenous Leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146547830272","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Stem Cell Transplantation for Secondary Acute Myeloid Leukemia: Evaluation of Transplantation as Initial Therapy or Following Induction Chemotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168808702592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168809737600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Optimal time and threshold of absolute lymphocyte count recovery as a prognostic factor after single‐unit cord blood transplantation in adults"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706974610304","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cryopreserved CD34+ Cell Dose, but Not Total Nucleated Cell Dose, Influences Hematopoietic Recovery and Extensive Chronic Graft-versus-Host Disease after Single-Unit Cord Blood Transplantation in Adult Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709185590528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Myeloablative single-unit cord blood transplantation overcomes the negative prognostic impact of FLT3-ITD in adult acute myeloid leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292618870365056","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619191412096","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292620709686400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643828409344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Momentum of neutrophil recovery using an exponential growth model predicts the prognosis of single cord blood transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302864779127936","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Higher Cryopreserved CD34+ Cell Dose Is Associated with Decreased Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Single-Unit Cord Blood Transplantation in Adults Given Prophylactic Ursodeoxycholic Acid and Intravenous Heparin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302865556448896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Low urinary sodium-to-potassium ratio in the early phase following single-unit cord blood transplantation is a predictive factor for poor non-relapse mortality in adults"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182218165632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Severe infusion-related toxicity after a second unrelated cord blood transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184162176768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Long-term persistent donor–recipient mixed chimerism without disease recurrence after myeloablative single-unit cord blood transplantation in adult acute myeloid leukemia following myelodysplastic syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094283991552","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118761639680","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Long-term outcomes following the addition of granulocyte colony-stimulating factor-combined high-dose cytarabine to total body irradiation and cyclophosphamide conditioning in single-unit cord blood transplantation for myeloid malignancies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118803517568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Total body irradiation-based versus busulfan-based myeloablative conditioning for single-unit cord blood transplantation in adults"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579820493421696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Intensified conditioning regimens improved disease‐free survival and engraftment after unrelated single‐unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584339775309440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pretransplantation EASIX Score Predicts Nonrelapse and Overall Mortality of Adult Patients Undergoing Single-Unit Unrelated Cord Blood Transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846640751414272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cytokine Profiles of Pre-Engraftment Syndrome after Single-Unit Cord Blood Transplantation for Adult Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659138837888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of hematogones on the long-term outcomes of single-unit cord blood transplantation for adult patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848661690294016","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855568770200960","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593768635904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prognostic impacts of peripheral blood erythroblasts after single‐unit cord blood transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361131417239546880","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Significance of Granulocyte Colony-Stimulating Factor-Combined High-Dose Cytarabine, Cyclophosphamide, and Total Body Irradiation in Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignant Neoplasms"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044167330176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519569326208","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994732394368","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995036383232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699996023686784","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470667917952","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Chronic graft-versus-host syndrome in man"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262943302299008","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262944908544640","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945786682880","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Umbilical cord blood transplantation: the first 25 years and beyond"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945805050112","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Unrelated cord blood transplantation after myeloablative conditioning in adults with advanced myelodysplastic syndromes"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262946215583616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418812840064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419112403968","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Allogeneic Stem Cell Transplantation for Adults with Myelodysplastic Syndromes: Importance of Pretransplant Disease Burden"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420971042176","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544421180953984","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Proportional Hazards Model for the Subdistribution of a Competing Risk"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893537938816","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895028274688","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Recombinant human granulocyte colony-stimulating factor (G-CSF) combined conditioning regimen for allogeneic bone marrow transplantation (BMT) in standard-risk myeloid leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895236923136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368828155264","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effect of Priming with Granulocyte Colony-Stimulating Factor on the Outcome of Chemotherapy for Acute Myeloid Leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370131160960","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"G-CSF and its receptor in myeloid malignancy"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388843560099200","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"High Disease Burden Is Associated with Poor Outcomes for Patients with Acute Myeloid Leukemia Not in Remission Who Undergo Unrelated Donor Cell Transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845133872768","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319700898432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo"}]},{"@id":"https://cir.nii.ac.jp/crid/1370288370391228934","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"High-dose Preparatory Regimens"}]},{"@id":"https://cir.nii.ac.jp/crid/1370288370391229192","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205420517376","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"骨髄系腫瘍, 急性リンパ性白血病に対する強化移植前処置の意義"},{"@language":"en","@value":"Significance of an intensified myeloablative conditioning regimen for myeloid malignancy and acute lymphoblastic leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1390022457808124928","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"臍帯血移植と維持療法で再発ハイリスク白血病に挑む"},{"@language":"en","@value":"The challenge of cord blood transplantation and maintenance therapy for high-relapse-risk leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1390577277031571968","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Japanese experience of single-unit cord blood transplantation for adults"},{"@language":"ja","@value":"本邦における成人に対する単一ユニットを用いた臍帯血移植"}]},{"@id":"https://cir.nii.ac.jp/crid/1390852724622520576","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Conditioning regimen of single-unit cord blood transplantation for hematological malignancy"},{"@language":"ja","@value":"造血器腫瘍に対する臍帯血移植の移植前処置"}]},{"@id":"https://cir.nii.ac.jp/crid/1391412326422449920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Disseminated Tuberculosis with Cholecystitis in a Patient after Cord Blood Transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1391412881282374016","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The Future Prospects of Cord Blood Transplantation―A Japanese Perspective―"},{"@language":"ja","@value":"臍帯血移植の未来展望―日本の見地から―"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.bbmt.2013.12.555"},{"@type":"KAKEN","@value":"PRODUCT-14161073"},{"@type":"KAKEN","@value":"PRODUCT-15128771"},{"@type":"KAKEN","@value":"PRODUCT-15129097"},{"@type":"KAKEN","@value":"PRODUCT-14577242"},{"@type":"KAKEN","@value":"PRODUCT-15185751"},{"@type":"KAKEN","@value":"PRODUCT-15128792"},{"@type":"KAKEN","@value":"PRODUCT-15129120"},{"@type":"OPENAIRE","@value":"doi_dedup___::04ee1f1ff1795cc0fd3fad054aefcedf"},{"@type":"CROSSREF","@value":"10.3109/10428194.2016.1171860_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1080/10428194.2020.1834096_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1093/jjco/hyaa250_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1038/s41375-021-01474-0_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1002/jha2.372_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.7889/tct-25-003_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1080/10428194.2019.1579325_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1016/j.transproceed.2019.01.079_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1111/ijlh.13636_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.7889/tct-22-026_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1016/j.jtct.2022.08.013_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1002/hon.3094_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1038/s41598-024-51748-7_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1080/10428194.2017.1318440_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.7889/hct-17-015_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.7889/tct-21-006_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1007/s00277-021-04676-9_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1080/10428194.2021.2018583_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1016/j.jtct.2023.06.021_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1080/10428194.2016.1180687_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1182/blood-2015-04-642652_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1111/ijlh.13622_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.4923-20_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1016/j.bbmt.2017.07.020_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1016/j.jcyt.2017.05.004_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.1016/j.bbmt.2017.03.036_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"},{"@type":"CROSSREF","@value":"10.7889/hct-20-021_references_DOI_aSnqhyeBt5eQlmIFoOEV0DTdyso"}]}